Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Ju‐Dong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9100-5960; OpenAlex author ID A5049322582, A5135044965. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 5

  1. Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L-mediated drug inactivation. Co-author DOI 10.1002/imt2.70126↗
  2. Impact of preoperative body weight on short-term and long-term prognosis after pancreatic resection for pancreatic ductal adenocarcinoma: a multicenter study. Co-author DOI 10.21037/jgo-2025-1-1022↗
  3. PLXDC1+ Tumor-Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202415756↗
  4. Identifying Liver Metastasis-Related Genes Through a Coexpression Network to Construct a 5-Gene Model for Predicting Pancreatic Ductal Adenocarcinoma Patient P… Co-author DOI 10.1097/mpa.0000000000002229↗
  5. Development of a Gene Risk Signature for Patients of Pancreatic Cancer. Co-author DOI 10.1155/2022/4136825↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenghao Shao · 5 shared papers, 2022–2026 · strength 1.09
  2. Ting Niu · 2 shared papers, 2026 · strength 0.53
  3. Xing Liang · 2 shared papers, 2022–2023 · strength 0.33
  4. Jun‐Feng Peng · 1 shared paper, 2026 · strength 0.29
  5. Kan Ding · 1 shared paper, 2026 · strength 0.29
  6. Youqiong Ye · 1 shared paper, 2025 · strength 0.22
  7. Yanhua Du · 1 shared paper, 2025 · strength 0.22
  8. Hamid Alinejad‐Rokny · 1 shared paper, 2025 · strength 0.22
  9. Duowu Zou · 1 shared paper, 2025 · strength 0.22
  10. Tao Liu · 1 shared paper, 2023 · strength 0.18
  11. An‐An Liu · 1 shared paper, 2023 · strength 0.18
  12. Long Chen · 1 shared paper, 2022 · strength 0.16
  13. Tao Liu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.